Display options
Cite
Satopää J, Meretoja A, Koivunen RJ, et al. Treatment of intracerebellar haemorrhage: Poor outcome and high long-term mortality. Surg Neurol Int. 2017;8:272doi: 10.4103/sni.sni_168_17.
Satopää, J., Meretoja, A., Koivunen, R. J., Mustanoja, S., Putaala, J., Kaste, M., Strbian, D., Tatlisumak, T., & Niemelä, M. R. (2017). Treatment of intracerebellar haemorrhage: Poor outcome and high long-term mortality. Surgical neurology international, 8272. https://doi.org/10.4103/sni.sni_168_17
Satopää, Jarno, et al. "Treatment of intracerebellar haemorrhage: Poor outcome and high long-term mortality." Surgical neurology international vol. 8 (2017): 272. doi: https://doi.org/10.4103/sni.sni_168_17
Satopää J, Meretoja A, Koivunen RJ, Mustanoja S, Putaala J, Kaste M, Strbian D, Tatlisumak T, Niemelä MR. Treatment of intracerebellar haemorrhage: Poor outcome and high long-term mortality. Surg Neurol Int. 2017 Nov 09;8:272. doi: 10.4103/sni.sni_168_17. eCollection 2017. PMID: 29204307; PMCID: PMC5691556.
Copy Download .nbib Format: NLM
Share it on

Surg Neurol Int. 2017 Nov 09;8:272. doi: 10.4103/sni.sni_168_17. eCollection 2017.

Treatment of intracerebellar haemorrhage: Poor outcome and high long-term mortality.

Surgical neurology international

Jarno Satopää, Atte Meretoja, Riku J Koivunen, Satu Mustanoja, Jukka Putaala, Markku Kaste, Daniel Strbian, Turgut Tatlisumak, Mika R Niemelä

Affiliations

  1. Department of Neurosurgery, Helsinki University Hospital and Clinical Neurosciences, Neurology, University of Helsinki, Helsinki, Finland.
  2. Department of Neurology, Helsinki University Hospital and Clinical Neurosciences, Neurology, University of Helsinki, Helsinki, Finland.
  3. Department of Medicine at the Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia.
  4. Department of Anesthesiology, Päijät-Häme Central Hospital, Lahti, Finland.
  5. Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  6. Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.

PMID: 29204307 PMCID: PMC5691556 DOI: 10.4103/sni.sni_168_17

Abstract

BACKGROUND: Intracerebellar haemorrhage constitutes around 10% of all spontaneous, non-aneurysmal intracerebral haemorrhages (ICHs) and often carries a grim prognosis. In symptomatic patients, surgical evacuation is usually regarded the standard treatment. Our objective was to compare the in-hospital mortality and functional outcome at hospital discharge in either medically or surgically treated patients, and the impact of either treatment on long-term mortality after a cerebellar ICH.

METHODS: An observational, retrospective, single-centre consecutive series of 114 patients with cerebellar ICH. We assessed the effect of different demographic factors on functional outcome and in-hospital mortality using logistic regression. We also divided the patients in medical and surgical treatment groups based on how they had been treated and compared the clinical and radiological parameters, in-hospital, and long-term mortality in the different groups.

RESULTS: In our series, 38 patients (33.3%) underwent haematoma evacuation and 76 (66.7%) received medical treatment. Glasgow coma scale <8, blocked quadrigeminal cistern, and severe hydrocephalus were associated with in-hospital death or poor functional outcome at discharge (modified Rankin scale 4-6). Surgically treated patients were younger, had larger haematomas both in volume and diameter, were in a worse clinical condition, and suffered more from hydrocephalus and brainstem compression. There were no statistically significant differences in in-hospital or long-term mortality. However, the surgically treated patients remained in a poor clinical condition.

CONCLUSIONS: Surgical treatment of cerebellar ICH can be life-saving but often leads to a poor functional outcome. New studies are needed on long-term functional outcome after a cerebellar ICH.

Keywords: Cerebellum; intracerebral haemorrhage; long-term mortality; outcome

Conflict of interest statement

There are no conflicts of interest.

References

  1. Neurosurgery. 2001 Dec;49(6):1378-86; discussion 1386-7 - PubMed
  2. Int J Stroke. 2014 Oct;9(7):840-55 - PubMed
  3. Neurosurgery. 1994 Feb;34(2):246-50; discussion 250-1 - PubMed
  4. World Neurosurg. 2012 Mar-Apr;77(3-4):507-11 - PubMed
  5. Neurocrit Care. 2016 Dec;25(3):365-370 - PubMed
  6. J Neurosurg. 1978 Apr;48(4):575-9 - PubMed
  7. Stroke. 2015 Jul;46(7):2032-60 - PubMed
  8. J Trauma. 1998 May;44(5):839-44; discussion 844-5 - PubMed
  9. Cerebrovasc Dis. 2000 Mar-Apr;10 (2):93-6 - PubMed
  10. Neurocrit Care. 2014 Oct;21(2):192-9 - PubMed
  11. Cerebellum. 2012 Dec;11(4):939-45 - PubMed
  12. Neurology. 1986 Jun;36(6):858-60 - PubMed
  13. Acta Neurochir (Wien). 1994;131(1-2):59-66 - PubMed
  14. Neurosurgery. 2010 Nov;67(5):1243-51; discussion 1252 - PubMed
  15. Stroke. 2001 Feb;32(2):530-4 - PubMed
  16. Neurosurg Rev. 2011 Jan;34(1):77-86 - PubMed
  17. J Neurosurg. 1987 Oct;67(4):545-52 - PubMed
  18. Acta Neurochir (Wien). 1993;122(1-2):39-44 - PubMed
  19. Clin Neurol Neurosurg. 2013 Jul;115(7):863-9 - PubMed
  20. J Neurosurg. 1989 May;70(5):755-8 - PubMed
  21. Acta Neurochir (Wien). 2012 Jul;154(7):1189-95 - PubMed
  22. J Cerebrovasc Endovasc Neurosurg. 2015 Sep;17(3):185-93 - PubMed
  23. J Nerv Ment Dis. 1965 Jan;140:38-57 - PubMed
  24. Eur Neurol. 2004;52(2):112-9 - PubMed
  25. Cerebrovasc Dis. 2002;14 (3-4):207-13 - PubMed
  26. Stroke. 2005 May;36(5):934-7 - PubMed
  27. Stroke. 1996 Aug;27(8):1304-5 - PubMed
  28. J Clin Neurosci. 2012 Sep;19(9):1236-41 - PubMed

Publication Types